Conduit Pharmaceuticals- Warrants (22/09/2028) Total Revenue

The latest total revenue for CDTTW is $2.9B as of June 2026. That compares with $2.6B in the prior-year period — up 9.7% year over year. That is above the sector sector average of $1.3B. Investors often review this figure alongside Conduit Pharmaceuticals- Warrants (22/09/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CDTTW's total revenue moved from $2.6B to $2.9B — a 9.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Conduit Pharmaceuticals- Warrants (22/09/2028)'s operating scale or balance-sheet position.

Against its sector companies, CDTTW currently prints $2.9B for total revenue, while the sector average sits near $1.3B. That is roughly 113.6% above the sector mean. Large gaps often invite a closer look at Conduit Pharmaceuticals- Warrants (22/09/2028)'s growth, margins, and balance sheet.

A total revenue figure of $2.9B for CDTTW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $1.3B. Explore the charts below for those layers of context.

After noting CDTTW's total revenue ($2.9B), review year-over-year change from $2.6B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.